Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Champions Oncolog (CSBR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away?

Champions Oncology (CSBR) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

BSTC : 71.62 (+5.35%)
CSBR : 9.81 (+1.55%)
Champions Oncology Participates in Pre-Clinical Studies to Identify Novel Therapy for Childhood Cancer

HACKENSACK, NJ / ACCESSWIRE / December 17, 2018 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development...

CSBR : 9.81 (+1.55%)
Champions Oncology Reports Quarterly Revenue of $6.7 Million

CSBR : 9.81 (+1.55%)
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced...

CSBR : 9.81 (+1.55%)
Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Champions Oncology (CSBR) closed at $10.39, marking a +0.39% move from the previous day.

CSBR : 9.81 (+1.55%)
Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know

Champions Oncology (CSBR) closed the most recent trading day at $12.41, moving -1.43% from the previous trading session.

CSBR : 9.81 (+1.55%)
Patients Launch New Study to Shed Light on EGFR-Positive Lung Cancers

The Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology and EGFR Resisters today announced the launch of a new study to create a novel bank of patient derived xenograft (PDX) models to help...

CSBR : 9.81 (+1.55%)
Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference

Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced...

CSBR : 9.81 (+1.55%)
Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know

Champions Oncology (CSBR) closed at $13.43 in the latest trading session, marking a +1.13% move from the prior day.

CSBR : 9.81 (+1.55%)
Champions Oncology Sees Hammer Chart Pattern: Time to Buy?

Champions Oncology has been struggling lately, but the selling pressure may be coming to an end soon.

CSBR : 9.81 (+1.55%)
Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year?

Is (CSBR) Outperforming Other Medical Stocks This Year?

CSBR : 9.81 (+1.55%)
Champions Oncology (CSBR) Gains As Market Dips: What You Should Know

Champions Oncology (CSBR) closed at $12.21 in the latest trading session, marking a +0.58% move from the prior day.

CSBR : 9.81 (+1.55%)
Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year?

Is (CSBR) Outperforming Other Medical Stocks This Year?

CSBR : 9.81 (+1.55%)
Affimed Down After Clinical Hold on Two Early-Stage Studies

Affimed (AFMD) puts two phase I studies evaluating its CD19/CD3-targeting T cell engager, AFM11, on clinical hold due to one death and two life-threatening events.

AFMD : 3.42 (-1.72%)
RHHBY : 34.0200 (+0.80%)
CSBR : 9.81 (+1.55%)
BSTC : 71.62 (+5.35%)
Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that management...

CSBR : 9.81 (+1.55%)
Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that management...

CSBR : 9.81 (+1.55%)
Blog Exposure - Lexicon Announced NDA and MAA Submissions for Sotagliflozin to Treat Adults with Type-1 Diabetes

Stock Monitor: Champions Oncology Post Earnings Reporting

LXRX : 5.35 (+4.49%)
CSBR : 9.81 (+1.55%)
Champions Oncology, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 15, 2018 / Champions Oncology, Inc. (NASDAQ: CSBR) will be discussing their earnings results in their Q3 Earnings Call to be held on March 15, 2018, at 4:30 PM Eastern...

CSBR : 9.81 (+1.55%)
Champions Oncology Reports Quarterly Revenue of $5.1 Million

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial...

CSBR : 9.81 (+1.55%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX -0.33
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar